Corcept Therapeutics
CORT
#1631
Rank
S$16.77 B
Marketcap
S$155.17
Share price
2.24%
Change (1 day)
35.45%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): S$8.68 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are S$0.83 Billion. In 2025 the company made an earning of S$57.35 Million a decrease over its 2024 earnings that were of S$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$8.68 M-84.85%
2025 S$57.35 M-67.29%
2024 S$0.17 B27.66%
2023 S$0.13 B-4.75%
2022 S$0.14 B-9.51%
2021 S$0.15 B-2.91%
2020 S$0.16 B14.87%
2019 S$0.14 B24.71%
2018 S$0.11 B69.32%
2017 S$67.67 M419.26%
2016 S$13.03 M-395.64%
2015 -S$4.41 Million-87.53%
2014 -S$35.37 Million-33.44%
2013 -S$53.14 Million
2011 -S$41.4 Million17.84%
2010 -S$35.14 Million35.5%
2009 -S$25.93 Million2.84%
2008 -S$25.21 Million60.81%
2007 -S$15.68 Million-52.14%
2006 -S$32.76 Million20.91%
2005 -S$27.1 Million31.87%
2004 -S$20.55 Million60.54%
2003 -S$12.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.55 B 409,080.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$19.87 B 242,241.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$8.84 B 107,737.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$43.01 B 524,421.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.84 B 119,962.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$15.24 B 185,848.48%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-S$62.3 Million-859.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.10 B 1,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.19 B 2,228.02%๐Ÿ‡บ๐Ÿ‡ธ USA